PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Oct-2020 First Commercial Drug Manufactured via Ajinomoto Bio-Pharma Services' AJIPHASE Technology Receives FDA Approval Ajinomoto Bio-Pharma Services
06-Oct-2020 Biotest AG: Biotest treats first COVID-19 patient with trimodulin Biotest AG
06-Oct-2020 Biotest AG: Biotest treats first COVID-19 patient with trimodulin Biotest AG
06-Oct-2020 Breakthrough 2020: ArisGlobal Announces Virtual Event for Life Sciences R&D Professionals Set for October 2020 ArisGlobal
06-Oct-2020 The Lancet Gastroenterology and Hepatology publishes InDex Pharmaceuticals' results of the phase IIb study with cobitolimod InDex Pharmaceuticals
05-Oct-2020 Hematogenix Unites With 19 Organizations from the Healthcare Community to Form COVID-19 Testing Industry Consortium Hematogenix
05-Oct-2020 Thrive Bioscience Launches the CellAssist to Provide Imaging, Analytics, and Documentation for Reproducible Cell Culture Thrive Bioscience, Inc.
05-Oct-2020 Thrive Bioscience Launches the CellAssist to Provide Imaging, Analytics, and Documentation for Reproducible Cell Culture Thrive Bioscience, Inc.
05-Oct-2020 Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar Medicure Inc.
05-Oct-2020 Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th VirtualInvestorConferences.com
05-Oct-2020 Non-Muscle Invasive Bladder Cancer (NMIBC) Market is increasing with ~ 8% CAGR during the study period (2017-2030), according to DelveInsight DelveInsight Business Research, LLP
05-Oct-2020 MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines Mind Medicine (MindMed) Inc.
04-Oct-2020 Debiopharm and the Japanese Cancer Association Announce Winners of the 2020 JCA-Mauvernay Award Debiopharm International SA
04-Oct-2020 Biotest AG: Biotest AG
03-Oct-2020 Siemens Healthineers AG: Disclosure pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014 (MAR) and Art. 2 para. 1 of Delegated Regulation (EU) No. 2016/1052 Siemens Healthineers AG
03-Oct-2020 Novartis announces five-year data that reinforce the safety and efficacy profile of Aimovig® (erenumab-aooe) in adult patients with episodic migraine Novartis
02-Oct-2020 FDA Approves Drug Combination for Treating Mesothelioma U.S. Food and Drug Administration
02-Oct-2020 Physician-Scientist Dr. Steven Quay Provides Best-Selling Book, "Stay Safe: A Physician's Guide to Survive Coronavirus," to the White House Upon the News of COVID in the First Family Dr. Steven Quay
02-Oct-2020 BiondVax Announces At-The-Market (ATM) Equity Offering Program BiondVax Pharmaceuticals Ltd.
02-Oct-2020 BrainStorm Cell Therapeutics to Announce Third Quarter Financial Results and Provide a Corporate Update Brainstorm Cell Therapeutics Inc